My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Uber, WeRide Move Closer to Driverless Rides...
Ford Blasts Transportation Secretary Duffy Ov...
American Eagle Stock Hits 11-Month Lows, Anal...
Meta’s AI Agents Are Coming for Your Shopping...
A Possible eBay Retreat and a Q2 Revenue Beat...
Dan Ives Says Apple’s $1,999 Foldable Could D...
Macy’s Weak Profit Outlook Sends Stock Lower
Goldman Sachs Increases COIN Target to $219 o...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    GUGGENHEIM STRATEGIC OPPORTUNITIES (NYSE: GOF)

    Overview
    current price
    $9.17
    $9.17
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    9.17
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    2.79 M
    1 day
    0.00 - 0.00
    52 weeks
    8.96 - 15.11
    p/e
    0.00
    beta
    0.6273
    market cap
    1.49 B
    dividend yield
    23.83%
    Industry
    -
    GOF by TradingView
    News and Commentary
    Regeneron Antibody Therapy Showing Promise A coronavirus antibody treatment being tested by Regeneron
    IPO Update: Casper Sleep Invests in the "Sleep Economy" Well-know private mattress maker Casper Sleep filed its S-1 paperwork with the U.S. Securities and Exchange Commission on Friday. The company views itself as a major player in th...
    StockTwits
    StockTwits
    Most Shared
    Dollar Tree Says Higher Fuel Prices Are Becoming a ‘Very, Very Meaningful’ Headwind
    Apple iPhone Duo Starts at $1,999 With 7.6-Inch Foldable Display: AAPL CEO John Ternus Says No More ‘Two Phones Awkwardly Stuck Together’
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Most Popular
    Quantinuum Strikes Oracle Deal as Quantum Cloud Race Heats Up: ‘Next Phase of Enterprise Computing’
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Musk's Grok 4.6 Jumps to AI Frontier, Matches OpenAI at a Fraction of the Price
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?